Xenico Pharma®
Xenico Pharma® is a privately held Polish nutraceutical company that develops, manufactures, and distributes proprietary branded dietary supplements across vitamins, minerals, probiotics, and specialty health categories, selling exclusively in Poland through its own e-commerce store, the Ceneo marketplace, and a B2B wholesale platform.
- Company typePrivate
- Founded2016
- HeadquartersWrocław, Poland
- Headcount1–10
- GTM typeB2C
- OfferingHardware or Manufacturing
What Xenico Pharma® does
Xenico Pharma® (legal name: XENICO PHARMA Sp. z o.o.) is a privately held Polish dietary supplement and nutraceutical company founded in 2016 and headquartered in Wrocław, Poland. The company develops, manufactures, and distributes a portfolio of branded supplement lines across vitamins (XeniVit®), bone and cardiovascular health (Menachinox®, Bergamil®, Monolipid®), iron (Bioradix®, Żelazo Organiczne), minerals (Cynk Organiczny, Selen Organiczny, Potas Organiczny, Cytrynian Magnezu), probiotics (ProbiotiX+), electrolytes (Litoxen), joint health (Natiflex Osteum, Artroxen), immune support (Immunocare™, Colostrum bovinum), and cognitive support (Ginkomag Plus, Urydyxen). Products use bioavailability-optimized active ingredient forms (methylcobalamin B12, P-5-P B6, L-methylfolate, anhydrous magnesium citrate, chelated iron) and multiple delivery formats including softgel capsules, Vcaps® plant-based capsules, DRcaps® enteric capsules, effervescent tablets, lozenges, and liquid formulations. Five of the brands (Bergamil®, Menachinox®, Monolipid®, XeniVit®, Bioradix®) are registered brand identities. Manufacturing is conducted under GMP standards with verified European raw material suppliers and accredited laboratory testing.
The company operates a horizontal, multi-channel distribution model focused exclusively on the Polish market. Channels include a proprietary direct-to-consumer e-commerce store (xenico24.pl), presence on the Ceneo price-comparison and marketplace platform, and a dedicated B2B wholesale portal (xenicob2b.pl) targeting mid-market resellers and retailers. The customer base consists of health-conscious consumers, with secondary use-case segments spanning diabetics, seniors, vegans/vegetarians, and individuals seeking cardiovascular, joint, or bone health support. The company operates with a very lean team of 6 employees, relies on a content-marketing blog ('Blog ekspercki') and Ceneo verified reviews for demand generation, and is independently owned with no disclosed external funding, parent company, M&A activity, or institutional investment. Customer concentration is distributed across thousands of individual retail buyers, with no large enterprise anchors identified.
Xenico Pharma® firmographics
Firmographics- Name
- Xenico Pharma®
- Legal name
- XENICO PHARMA Sp. z o.o.
- Website
- https://xenico.pl
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Xenico Pharma® is a privately held Polish nutraceutical company that develops, manufactures, and distributes proprietary branded dietary supplements across vitamins, minerals, probiotics, and specialty health categories, selling exclusively in Poland through its own e-commerce store, the Ceneo marketplace, and a B2B wholesale platform.
- Ownership category
- akta.pro rank
Xenico Pharma® industry classification
Industry- Product category
- Dietary Supplements
- NAICS
- Pharmaceutical and Medicine Manufacturing (3254)
- SIC
- Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Delivery Systems & Encapsulation (Microencapsulation, Liposomes, Emulsions, Beadlets, Spray-Dried) (AFAJAKAL)
Keywords
Where Xenico Pharma® is headquartered
LocationHeadquarters
- HQ city
- Wrocław
- HQ country
- Poland
- HQ region
- Europe
Offices1 record
Markets served
Xenico Pharma® business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D
Revenue model
- Dietary Supplements Sales: Sale of proprietary dietary supplements and nutraceuticals through direct-to-consumer e-commerce and marketplace channels
- B2B Wholesale: Wholesale distribution to retailers and business customers through xenicob2b.pl platform
Go-to-market motion2 records
Distribution channels3 records
Marketing channels3 records
Xenico Pharma® product offering
Product offeringCore offering
Xenico Pharma® develops and manufactures proprietary dietary supplements and nutraceuticals under patented brands including Bergamil® (bergamot extract), Menachinox® (Vitamin K2 + D3), Monolipid® (cholesterol management), XeniVit® (vitamins and minerals), and Bioradix® (organic liquid iron). The company uses advanced delivery formats such as Softgel capsules, Vcaps® plant-based capsules, and DRcaps® enteric capsules, employing clinically studied active ingredient forms like methylcobalamin, P-5-P, and L-methylfolate for high bioavailability. Products are manufactured under GMP standards with verified European raw material suppliers and emphasize clean-label formulations without preservatives, gluten, lactose, GMOs, or artificial additives.
Product overview
Xenico Pharma® is a Polish pharmaceutical company specializing in modern dietary supplements and nutraceuticals. The product portfolio consists of multiple branded product lines including XeniVIT (vitamins and minerals), Menachinox® (bone health with K2 and D3), Bergamil® (bergamot extract for cardiovascular health), Monolipid® (cholesterol support), ProbiotiX+ (probiotics), Litoxen (electrolytes), and Xenico® (organic minerals, ginseng, and specialty supplements). The company uses innovative delivery formats including Vcaps® plant-based capsules, Softgel capsules, and DRcaps enteric capsules. Key product categories cover vitamins (B-complex, C, D, K), minerals (magnesium, iron, zinc, selenium, potassium), herbal extracts (ginseng, berberine, ginkgo), joint health (glucosamine, collagen, chondroitin), immune support (colostrum, echinacea, acerola), and nutricosmetics. Products are manufactured under GMP standards with verified European raw material suppliers and emphasize clean labels without preservatives, gluten, GMOs, or artificial additives.
Differentiator
Problem solved
Functional benefit
Brands
- Bergamil®: Patented brand featuring standardized bergamot extract, marketed for cholesterol support.
- Menachinox®
- Monolipid®
- XeniVIT®
- Bioradix
- ProbiotiX+
- Litoxen
- Ginkomag Plus
- Natiflex Osteum
- Artroxen
- Immunocare™
- Collagen FAST
- Urydyxen
Products and services
- Bergamil® Patented branded line of standardized bergamot extract supplements marketed for cardiovascular health support and cholesterol management. Includes Bergamil® Forte capsules.
- Menachinox® Patented branded line of vitamin K2 and D3 combination supplements without artificial additives, including Menachinox® ADEK, Menachinox® K2 + D3 (2000/4000 IU variants), and Menachinox® OSTEO for bone mineral density in women aged 40+.
- Monolipid® Patented branded line of supplements for maintaining healthy cholesterol levels, including Monolipid K® and Monolipid K Forte containing monacolin K from red yeast rice.
- XeniVit® Patented branded vitamin and mineral supplement line including XeniVit Witamina B12 Active (methylcobalamin), B Complex Premium (all active B forms), bio Acerola C 1000, Vitamin D forte, and Multi Active effervescent multivitamin.
- Bioradix® Patented branded organic iron supplement in liquid form based on honey, herbal extracts, and concentrated fruit juices. Alcohol- and preservative-free, supporting immune and nervous system function.
- ProbiotiX+ Probiotic supplement line providing essential bacterial cultures to support gut microbiota and immune function, including IBS-specific formulations combined with arabinogalactan and inulin.
- Litoxen Electrolyte supplement line for diabetics, seniors (Litoxen Senior with potassium, magnesium, sodium, chloride, glucose, and grape seed extract), and general use, supporting hydration and electrolyte balance.
- Ginkomag Plus
- Natiflex Osteum Comprehensive joint health supplement containing fish skin collagen (NatiCol®), chondroitin sulfate, hyaluronic acid, vitamin C, D3, and K2 MK-7.
- Artroxen Joint support supplement containing 1500 mg glucosamine sulfate, 600 mg MSM, ginger root extract, copper, and vitamin C.
- ImmunocareTM Immune support formula with six active ingredients including vitamin C, D3, zinc, standardized echinacea extract, elderberry extract, and garlic extract, enriched with Bioperine®.
- Collagen FAST Collagen supplement with 500 mg natural collagen hydrolysate and vitamin C in strawberry-flavored lozenges for skin, bones, cartilage, and connective tissue.
- Żelazo Organiczne Xenico® Organic iron supplement in chelated form with vitamin C for enhanced absorption, gentle on the digestive tract.
- Cytrynian Magnezu Xenico® Anhydrous magnesium citrate powder enriched with active vitamin B6 P-5-P for optimal absorption; sugar-free, gluten-free, suitable for diabetics.
- Colostrum bovinum Xenico® Premium bovine colostrum supplement using advanced lyophilization to preserve nutritional richness and immune-active compounds.
- Żeń-szeń Complex Xenico® Natural supplement combining extracts of three ginseng species (American, Korean, Siberian) standardized for ginsenosides and eleutherosides content, supporting energy and adaptogenic properties.
Quantifiable outcome
- Customer testimonials report positive outcomes for cholesterol management (Bergamil, Monolipid), joint health (Natiflex, Artroxen), and general wellness
Companies that use Xenico Pharma®
Customer profileNamed customers1 record
Segments6 records
Ideal customer profiles2 records
Xenico Pharma® technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Xenico Pharma® partnerships and signals
Strategic signalScale indicators2 records
Recent moves5 records
Expansion highlights4 records
Xenico Pharma® competitors and assessment
Company assessmentDirect peers
- Olimp Labs: Polish dietary supplement and nutraceutical brand manufacturer with similar product breadth across vitamins, minerals, herbal extracts, and joint health, competing in the same Polish D2C and pharmacy channels.
- Apollo's Hegemony: Polish emerging supplement brand focused on high-bioavailability, clean-label formulations sold primarily through e-commerce and Amazon EU; comparable target customer and formulation philosophy.
- Vitaler's: Polish dietary supplement e-commerce brand with overlapping vitamin, mineral, and specialty health categories; comparable D2C-led Polish-market business model.
- Aurea Pharma: Polish supplement brand offering vitamins, minerals, and herbal formulations via e-commerce; directly comparable scale, product mix, and Poland-centric GTM motion to Xenico Pharma.
Broad incumbents
- Doctor's Best: Science-positioned supplement brand with overlapping categories including vitamins, minerals, and specialty ingredients like CoQ10; comparable formulation philosophy centered on bioavailability and clinically studied ingredients.
- Solgar: Globally established premium vitamin and supplement brand owned by Nestlé Health Science; broad incumbent serving the same health-conscious consumer with overlapping vitamin, mineral, and herbal categories.
- NOW Foods: Large US-headquartered supplement manufacturer with extensive vitamins, minerals, herbal, and joint-health product lines; competes in the same supplement category through e-commerce and global distribution.
- Nature's Way: Established global supplement brand offering vitamins, herbal extracts, and probiotics; comparable product categories and target consumer, operating at much larger scale.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights6 records
Customer concentration
Xenico Pharma® social profiles
Digital presenceXenico Pharma® financial estimates
Financial estimateRevenue estimate
Valuation estimate
Xenico Pharma® leadership team
Management profileNumber of profiles
Xenico Pharma® funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Xenico Pharma® M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Xenico Pharma®
What does Xenico Pharma® do?
Xenico Pharma® develops and manufactures proprietary dietary supplements and nutraceuticals under patented brands including Bergamil® (bergamot extract), Menachinox® (Vitamin K2 + D3), Monolipid® (cholesterol management), XeniVit® (vitamins and minerals), and Bioradix® (organic liquid iron). The company uses advanced delivery formats such as Softgel capsules, Vcaps® plant-based capsules, and DRcaps® enteric capsules, employing clinically studied active ingredient forms like methylcobalamin, P-5-P, and L-methylfolate for high bioavailability. Products are manufactured under GMP standards with verified European raw material suppliers and emphasize clean-label formulations without preservatives, gluten, lactose, GMOs, or artificial additives.
Is Xenico Pharma® a public or private company?
Xenico Pharma® is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Xenico Pharma® founded?
Xenico Pharma® was founded in 2016. It employs 1 to 10 people.
Where is Xenico Pharma® based?
Xenico Pharma® is headquartered in Wrocław, Poland, in the Europe region.
How does Xenico Pharma® make money?
Two revenue lines are on record. Dietary Supplements Sales are the primary driver. The others are B2B Wholesale.
Who are Xenico Pharma®'s main competitors?
Direct peers on record are Olimp Labs, Apollo's Hegemony, Vitaler's and Aurea Pharma. Broad incumbents are Doctor's Best, Solgar, NOW Foods and Nature's Way.
Does Xenico Pharma® have an API?
No public API is recorded for Xenico Pharma®.
What industry is Xenico Pharma® in?
Xenico Pharma®'s product category is Dietary Supplements. Its primary akta.pro industry code is AFAJAKAL, Delivery Systems & Encapsulation (Microencapsulation, Liposomes, Emulsions, Beadlets, Spray-Dried). Its NAICS code is 3254 and its SIC code is 2833.